Matteo Massanova

@yang_kunlin @lee_c_zhao Don’t you taper the bowel?

Robotic right sided ileal ureter for long ureteral stricture after radiation therapy - Totally intracorporeal - 1.5h I don’t agree that they always say “Ileal ureter is a high risk complications surgery”. It’s a useful and irreplaceable choice for post-radiation patients

🚨 NEW #PlatinumOpinion in European Urology by M. J. Roberts, @GGandaglia et al : 💡 Is extended pelvic lymph node dissection (ePLND) still justified in prostate cancer? 📉 No oncologic benefit in RCTs ⚠️ Up to 20% complication rate 🧬 PSMA PET reshapes staging 🔄 2024 EAU Guidelines update: reconsider routine ePLND. 🔗 buff.ly/84dPAkb #EAUGuidelines #ProstateCancer #UroOncology #ePLND #PSMAPET #urotwitter

📢Publication alert! Highlights: 1⃣Across 11 trials, TMT was associated with lower OS and CSS than RC 2⃣RC should remain the standard of care for nonmetastatic MIBC 3⃣TMT remains a valid alternative for carefully selected and informed patients 🔗bit.ly/4e4KayS

Robotic-assisted cystectomy strategies: 🔬 21 expert surgeons analyzed 🤖 Demanding ileourethral approximation: 86% 🏗️ Studer/Bordeaux reconstructions popular 📉 Trendelenburg reduction: 43% #Urology #RARC #Neobladder #Pub2Post tinyurl.com/4kethxyf @MariaChiaraMCS @bernardorocco73 @Uroweb

Real-world outcomes for high-risk non-muscle-invasive #BladderCancer: screened patients for the BRAVO trial @S_Conroy91 @JimCatto doi.org/10.1111/bju.16…

Influence of a surgeon’s exposure to operating room turnover delays on patient outcomes ➡️doi.org/10.1093/bjsope… In this prospective study, a 3.3% (95% c.i. 0.6% to 5.6%) increase in the rate of major adverse events was observed when a surgeon experienced a delay in operating room scheduling or waiting time between two procedures exceeding 1 h. Optimizing operating room turnover to prevent delayed operations and waiting time is critical for patient safety. 👏👏👏Arnaud Pasquer, Quentin Cordier, Jean-Christophe Lifante, Gilles Poncet, Stéphanie Polazzi, Antoine Duclos #SoMe4Surgery #MedTwitter #SurgEd #Surgery @me4_so @BJSAcademy @BJSurgery @young_bjs @juliomayol @JJEarnshaw @OUPMedicine

Digital Rectal Examination Is Not a Useful Screening Test for Prostate Cancer - finally out. Early results from the PROBASE screening trial in younger men. Great team effort! sciencedirect.com/science/articl…

@RafaelFCoelho2 Can we please watch full unedited video of this?

@Issarami I usually reserve this for patients who need palliation with short life expectancy.

Where's the robot!? On a more serious note, this diversion option is very valuable when dealing with extremely morbid patients when you need the benefits of the cystectomy while reducing the risks associated with operating on the bowels!

@Issarami Totally agree, but all the headaches saved in the immediate post-operative recovery are often paid back on the mid-/long-term with multiple readmissions for dislodged stents, recurrent UTIs, stoma stenosis. Not to forget the need of keeping these patients on regular stent change.

💡This is the first report of vascularized #BladderTransplantation in a heart-beating, brain-dead human donor, with excellent vascular viability after reperfusion, and is a necessary #preclinical step before a first-in-human BT. ✅If clinically successful, BT could offer a bowel-free, more normal bladder substitute in selected patients with bladder failure. authors.elsevier.com/c/1hKfb14kplv9… @uro_nima @USC_Urology @EUplatinum @Uroweb @AmerUrological

@UroNoel @GuysUrology @GSTTnhs @benchallacombe @cbrownurology @prokarurol Well done Jo, great milestone! Aim to 1000 now 😜

This team performed my 100th RALP for #prostatecancer. I’m grateful to them, mentors and #juniordoctors @GuysUrology. A special thank you to the amazing #Nurses and theatre staff @GSTTnhs. #NHS

And should pN3 be taken off the TNM classification?

If you are looking to train in robotic prostate surgery and bladder cancer surgery in a high volume pelvic cancer unit with a strong focus on education @SNathanUK @Jkurol @greglshaw @4urology @ZaferTandogdu @lambwben @KelkarUro @UroSplice @veerukasi uclh.nhs.uk/work-with-us/c…

Proud that the service we offer at @MSEHospitals has been publicised in the local newspaper. Gaining local awareness is important, so patients know that top class treatments can be delivered at their doorstep. Thanks to my hardworking #team for the support. #urology #essex

@lambwben @CancerNel @NHSBartsHealth @NHSHomerton @BHRUT_NHS Congratulations and well deserved

Very please to have been appointed @CancerNel clinical lead for MDTs. Looking forward to working with partners at @NHSBartsHealth @NHSHomerton @BHRUT_NHS and @CancerNel to improve patient care and staff wellbeing

@Issarami @doculla @Uroweb @nairajesh @acesridhar Also, operating times in experienced surgeon are comparable in both approaches. So, yes, when the patient can go for either RARC or ORC, I do counsel about advantages of RARC 😂

@Issarami @doculla @Uroweb @nairajesh @acesridhar Unless patient/cancer characteristics do not allow a safe🤖 approach, RARC is first option IMHO. RAZOR, iROC don’t show any disadvantage for robotic vs open and rather quicker recovery and less DVT/PE or wound complications. Even cost has been shown to be not an issue anymore.

Inform the patient of the advantages and disadvantages of open radical cystectomy and robot-assisted radical cystectomy to allow selection of the proper procedure. #MIBC #BladderCancer #EAUGuidelines uroweb.org/guidelines/mus…

@acesridhar Thanks Ashwin, it means a lot coming from you 🙏🏻

@MM_Urology Looks awesome.

It is this time of the year again: TOP 10 GU Oncology clinical papers/trials in 2022: Some negative, some positive, but we learned from all! Feel free to add more & retweet & tag anyone involved This is not an exhaustive list! @OncoAlert @danafarber #OnwardFor2023